- Recent Funding
- Investors
- Adage Capital Management
Adage Capital Management portfolio
Adage Capital Management has 6 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.
About this page
Its most recent investment on record is Claris Bio's $118M Series B+ round in July 2026, alongside Novo Holdings, Janus Henderson Investors, Mass General Brigham Ventures and 5 others. By category, its portfolio leans toward Health and bio (6) and Manufacturing and industrial (1). It has co-invested with Janus Henderson Investors, RA Capital Management and Sofinnova Partners, most often Janus Henderson Investors (2 rounds).
What Adage Capital Management invests in
- Health and bio · 6 · 100%
- Manufacturing and industrial · 1 · 17%
- Data and analytics · 1 · 17%
- AI infrastructure and compute · 1 · 17%
- Robotics and hardware · 1 · 17%
Adage Capital Management recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $118M | Novo Holdings, Janus Henderson Investors, Mass General Brigham Ventures +5 | ||
| Series B+ · $287M | SilverArc Capital, Hengdian Group, TCG Crossover +6 | ||
| Series B+ · $250M | Fidelity Management & Research Company, T. Rowe Price | ||
| Series A · $125M | Transhuman Capital, LifeSci Venture Partners, Balyasny Asset Management +5 | ||
| Series B+ · $80M | Alter Venture Partners, Dell Technologies Capital, Wing VC +3 |
How Adage Capital Management invests
Adage Capital Management portfolio companies
CClaris Bio$118MSeries B+ · Jul 2026
CCorxel$287MSeries B+ · Jan 2026MMirador Therapeutics$250MSeries B+ · Jan 2026
AAmbros Therapeutics$125MSeries A · Dec 2025
SSiMa AI$80MSeries B+ · May 2021
DDelixbacker
| Company | Round with Adage Capital Management | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $118M | $175M | Jul 28, 2026 Series B+ |
Health and bio |
Series B+ · $287M | $287M | Jan 26, 2026 Series B+ |
Health and bio |
Series B+ · $250M | $650M | Jan 13, 2026 Series B+ |
Health and bio |
Series A · $125M | $125M | Dec 16, 2025 Series A |
AI infrastructure and compute |
Series B+ · $80M | $495M | Sep 28, 2026 Series B+ |
Health and bio |
backer | undisclosed | Nov 9, 2026 round |
Most frequent co-investors
JJanus Henderson Investors2 shared rounds · last Jul 28, 2026
RRA Capital Management2 shared rounds · last Jan 26, 2026
SSofinnova Partners1 shared round · last Jul 28, 2026
NNovo Holdings1 shared round · last Jul 28, 2026
MMass General Brigham Ventures1 shared round · last Jul 28, 2026
SSamsara Biocapital1 shared round · last Jul 28, 2026
AAisling Capital1 shared round · last Jul 28, 2026
CCatalio1 shared round · last Jul 28, 2026
AADAR1 Capital Management1 shared round · last Jul 28, 2026
IInvus1 shared round · last Jan 26, 2026
SSymBiosis1 shared round · last Jan 26, 2026
SSR One1 shared round · last Jan 26, 2026
Similar investors
HHealthier Capital6 companies · 4 deals in 12 mo
UUC Investments6 companies · 4 deals in 12 moHHBM Healthcare Investments6 companies · 3 deals in 12 mo
TThe FSE Group6 companies · 3 deals in 12 mo
TThird Rock Ventures6 companies · 2 deals in 12 mo
NNext Ventures6 companies · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 5 rounds on Recent Funding that name Adage Capital Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Adage Capital Management, which is a subset of its real portfolio. API: /api/v1/investors/adage-capital-management (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy